A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Clinical trial NCT07103174 · COMPLETED

Trial details

NCT number: NCT07103174
Sponsor: Shanghai Mabgeek Biotech.Co.Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2025-06-30
Primary completion: 2026-03-09
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.